FDA Approves New Device For Treating Pediatric Scoliosis

August 23, 2019

The FDA has approved a spinal tether device to treat idiopathic scoliosis in children in adolescents.   read more

Teva Announces Generic EpiPen Jr.

August 22, 2019

Teva Pharmaceutical Industries now offers a generic version of Mylan’s EpiPen Jr. The epinephrine auto-injector retails in most pharmacies for $300 for a 2-pack.  read more

Study Tests Flu Vaccines With Experimental Adjuvants

August 14, 2019

A clinical study by the National Institutes of Health will evaluate two seasonal flu vaccines with and without adjuvants.  read more

FDA Approves First Therapy for Rare Tumor

August 8, 2019

The FDA on August 2 approved the first treatment for tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.  read more

Pharmacists Can Now Provide Smoking Cessation Medication in Indiana

August 7, 2019

In Indiana, patients can now receive smoking cessation medications directly from pharmacists.  read more

FDA Approves Biosimilar to Rituxan

August 1, 2019

The FDA has approved RUXIENCE (rituximab-pvvr), a biosimilar to Rituxan, for the treatment of adult patients with non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and granulomatosis with polyangiitis and microscopic polyangiitis.  read more

Drug Manufacturers Settle with State of California Over Antitrust Allegations

July 31, 2019

Two drugmakers have agreed to pay California a nearly $70 million settlement over allegations they violated antitrust laws by keeping generics off the market.  read more

New Federal Data Reveals Alarming Opioid Statistics

July 18, 2019

A database maintained by the Drug Enforcement Administration has tracked 76 billion oxycodone and hydrocodone pain pills sold in the United States from 2006 to 2012.  read more

White House Abandons Plan to Overhaul Drug Rebates

July 12, 2019

The Trump administration has abandoned its plan to end manufacturer rebates given to PBMs.   read more

NCPA Offers Webinar on Impact of Track and Trace on Pharmacy

July 9, 2019

The NCPA is hosting a webinar on July 10 to provide an overview of current and future requirements of the Drug Supply Chain Security Act and discuss pharmacy practices and solutions to help pharmacies comply with those requirements.  read more